HOSPITAL UNIVERSITARIO RUBER
Departamento
Fudan University
Shangai, ChinaPublicaciones en colaboración con investigadores/as de Fudan University (2)
2023
-
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer
Future oncology (London, England), Vol. 19, Núm. 35, pp. 2349-2359
2022
-
AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
Therapeutic Advances in Medical Oncology, Vol. 14